• / Free eNewsletters & Magazine
  • / My Account
Home>ETFs and Mutual Funds: Why not both?

ETFs and Mutual Funds: Why not both?

Morningstar Articles

Fri, 3 May 2013

Shire Pharmaceuticals SHPGY recently announced that the FDA approved its Hunter syndrome therapy, Elaprase, for marketing. We're slightly raising our fair value estimate to account for this new addition to Shire's product portfolio. Shire received rights

Related Videos

  1. Key Findings From Our 529 Industry Study

    Our annual study examines how 529 college savings plans stack up on price, performance, and other factors versus non-plan mutual funds .

  2. MLP Closed -End Funds Gain Energy

    CEFs that focus on master limited partnerships performed exceedingly well in the first quarter, yet there are still large discounts among equity closed - end funds, says Morningstar's Cara Esser.

  3. Commodity Price Drop Creating CEF Bargains

    The recent sell-off of gold and other commodities has led to advantageous discounts for precious-metals CEFs, but the funds should remain a small portion of your portfolio.

©2017 Morningstar Advisor. All right reserved.